EUCTR2011-003815-46-NL进行中（未招募）不适用
Double blind placebo controlled randomized intervention study aiming at reducing dexamethasone related side effects in children with acute lymphoblastic leukemia (ALL). - how to survive the dex-days study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- Erasmus MC
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- written informed consent
- •- age 3-16
- •- histologically or cytologically confirmed acute lymphoblastic leukemia
- •- inclusion in DCOG ALL10 or ALL11 protocol or ALL R3 protocol
- •- able to comply with scheduled follow-up.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 50
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- patient or parent refusal
- •- anticipated compliance problems
- •- Underlying conditions which affect the absorption of oral medication
- •- pregnant or lactating patients
- •- current uncontrolled infection or any other complication which may interfere with dexamethasone treatment
- •- language barrier
- •- preexisting mental retardation syndrome
研究者
相似试验
已完成
不适用
DexaDagen-2 studyNL-OMON22781Princes Maxima Centre for pediatric oncology105
已完成
不适用
Double blind placebo controlled randomized intervention study to validate the beneficial effect of hydrocortisone on dexamethasone-induced neurobehavioral side effects in pediatric acute lymphoblastic leukemiaAcute lymphoblastic leukemiablood cancer10024324NL-OMON50327niversitair Medisch Centrum Utrecht106
进行中（未招募）
1 期
DexaDays-2 studyEUCTR2017-002738-22-NLPrincess Máxima Center of Pediatric Oncology105
已完成
3 期
Randomized double blind placebo-controlled intervention study to investigate effects of VITACEL extrinsic wheat fibers for maintenance of normal defecation by increasing fecal bulk in healthy subjectsRegular digestionDRKS00026262J. Rettenmaier & Söhne GmbH + Co KG64
已完成
不适用
Randomised double blind placebo controlled internet trial of probiotics and ankylosing spondylitis (PAS- trial)Ankylosing spondylitisMusculoskeletal DiseasesAnkylosing SpondylitisISRCTN36133252niversity of Wales, Swansea (UK)140